Leerink Partnrs Reduces Earnings Estimates for Owens & Minor

Owens & Minor, Inc. (NYSE:OMI) – Analysts at Leerink Partnrs dropped their FY2024 earnings per share (EPS) estimates for Owens & Minor in a report issued on Monday, November 4th. Leerink Partnrs analyst M. Cherny now anticipates that the company will post earnings of $1.48 per share for the year, down from their previous forecast of $1.55. The consensus estimate for Owens & Minor’s current full-year earnings is $1.55 per share. Leerink Partnrs also issued estimates for Owens & Minor’s Q4 2024 earnings at $0.50 EPS, Q2 2025 earnings at $0.47 EPS, Q4 2025 earnings at $0.51 EPS, FY2025 earnings at $1.75 EPS and FY2026 earnings at $2.16 EPS.

Owens & Minor (NYSE:OMI) last released its quarterly earnings data on Monday, November 4th. The company reported $0.42 EPS for the quarter, topping analysts’ consensus estimates of $0.41 by $0.01. Owens & Minor had a negative net margin of 0.46% and a positive return on equity of 14.60%. The firm had revenue of $2.72 billion during the quarter, compared to the consensus estimate of $2.68 billion. During the same quarter in the previous year, the company posted $0.44 earnings per share. The firm’s revenue was up 5.0% on a year-over-year basis.

A number of other brokerages have also recently weighed in on OMI. UBS Group dropped their price target on Owens & Minor from $28.00 to $25.00 and set a “buy” rating on the stock in a research report on Tuesday. JPMorgan Chase & Co. dropped their target price on Owens & Minor from $22.00 to $18.00 and set an “underweight” rating on the stock in a research report on Wednesday, August 21st. Robert W. Baird reduced their price target on shares of Owens & Minor from $19.00 to $14.00 and set a “neutral” rating for the company in a report on Tuesday. StockNews.com cut shares of Owens & Minor from a “buy” rating to a “hold” rating in a report on Monday, August 26th. Finally, Citigroup cut their price objective on shares of Owens & Minor from $21.00 to $18.50 and set a “buy” rating on the stock in a research report on Tuesday. Two research analysts have rated the stock with a sell rating, five have given a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $18.50.

Owens & Minor Price Performance

OMI opened at $13.61 on Thursday. The company has a quick ratio of 0.51, a current ratio of 1.09 and a debt-to-equity ratio of 2.11. The company’s 50-day moving average price is $14.41 and its 200 day moving average price is $16.08. Owens & Minor has a fifty-two week low of $11.42 and a fifty-two week high of $28.35. The firm has a market cap of $1.05 billion, a price-to-earnings ratio of -20.94, a price-to-earnings-growth ratio of 0.39 and a beta of 0.41.

Hedge Funds Weigh In On Owens & Minor

Several large investors have recently bought and sold shares of the stock. Quarry LP boosted its holdings in shares of Owens & Minor by 290.1% in the second quarter. Quarry LP now owns 2,099 shares of the company’s stock valued at $28,000 after acquiring an additional 1,561 shares in the last quarter. Blue Trust Inc. boosted its stake in Owens & Minor by 176.8% during the 3rd quarter. Blue Trust Inc. now owns 2,787 shares of the company’s stock valued at $44,000 after purchasing an additional 1,780 shares in the last quarter. Allspring Global Investments Holdings LLC increased its position in shares of Owens & Minor by 43,142.9% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 3,027 shares of the company’s stock valued at $84,000 after purchasing an additional 3,020 shares during the period. DekaBank Deutsche Girozentrale raised its stake in shares of Owens & Minor by 76.6% in the 2nd quarter. DekaBank Deutsche Girozentrale now owns 3,126 shares of the company’s stock worth $43,000 after buying an additional 1,356 shares in the last quarter. Finally, Innealta Capital LLC bought a new stake in shares of Owens & Minor in the 2nd quarter worth $43,000. Institutional investors and hedge funds own 98.04% of the company’s stock.

Owens & Minor Company Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.